Form D · Other Health Care
ElectraDx, Inc.
Boston, MA · CIK 0002015659
Offering snapshot reported Mar 20, 2024 · SEC filing
- Reported sold
- $14.8M Offering amount: $20M
- Investors reported
- 22 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 21, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2024 | Initial | $14,760,000 | No comparison | 22 | SEC filing |
| Mar 19, 2024 | Initial | $6,280 | No comparison | 57 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-508135
Source: Form D, filed Mar 20, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jerome Mc Aleer | Director, Executive |
| David Scott | Director, Executive |
| Ron Zwanziger | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
C/O Ruberto, Israel & Weiner, P.C. 255 State Street, 7 Th Floor
Boston, MA, 02109
Boston, MA, 02109